Spinol

Implantable Annulus Closure Device

Health Tech & Life Sciences
Active
Seed Modi'in-Maccabim-Re'ut Founded 2018
Website ↗
Total raised
Stage
Seed
Founded
2018
Headcount
3
HQ
Modi'in-Maccabim-Re'ut
Sector
Health Tech & Life Sciences

About

Spinol has developed a novel implantable annulus closure device that seals ruptured spinal discs and eliminates the risk of reherniation.

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is Spinol's primary product?
Spinol has developed an implantable annulus closure device called Octopus, designed to seal ruptured spinal discs and prevent reherniation.
When was Spinol founded?
Spinol was founded in October 2018.
Where is Spinol's headquarters located?
Spinol's headquarters is located in Modi'in-Maccabim-Re'ut, Center District, Israel.
What is Spinol's current product stage?
Spinol's product, Octopus, is currently in the clinical trial stage.
How many employees does Spinol have?
Spinol has 3 employees.
What is Spinol's primary sector?
Spinol's primary sector is Health Tech & Life Sciences, specifically focusing on Medical Devices and Medical Treatment & Therapeutics.
Does Spinol hold any patents?
Yes, Spinol holds 1 patent.
Who is a founder of Spinol?
Roey Shafrir is a founder of Spinol.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & Substances
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

surgeryhospitalshealthcare-providersclinicsmedical-devicesorthopedicsminimally-invasive